– EU ‘VAMPIRE’ PROJECT TO HELP DRUGS STARVE TUMOURS OF BLOOD FLOW
August 1st, 2013
A EUROPEAN Commission Euro EUR1.5 million grant will help pharmaceutical researchers discover antibodies that can eradicate a tumour by destroying its blood vessels. The so-called VAMPIRE project ('Vascular Antibody-Mediated Pharmaceutically Induced tumour Resection') is led by Britain’s University of Birmingham and SomantiX, a Dutch biotech company, based in Utrecht. Other participants include Swiss science and technology university ETH Zurich and Cancer Research UK.A SomantiX note said researchers would develop agents for imaging and treatingsolid cancers by ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.